Efficacy of CD34+ Stem Cell Dose in Patients Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation after Total Body Irradiation

Biology of Blood and Marrow Transplantation

Volumn 13, Issue 3, 2007, Pages 339-344

  Singh, Anurag K ^a   Savani, Bipin N ^b   Albert, Paul S ^a   Barrett, A John ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

CD34+ dose; Lung dose reduction; Lung shielding; Peripheral blood stem cell transplantation; Total body irradiation

Indexed keywords

CD34 ANTIGEN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DACLIZUMAB; FLUCONAZOLE; FLUDARABINE; INFLIXIMAB; STEROID;

ACUTE GRAFT VERSUS HOST DISEASE; ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; ARTICLE; CANCER MORTALITY; CANCER SURVIVAL; CD34 SELECTION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG MEGADOSE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HUMAN; INFECTION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PROPORTIONAL HAZARDS MODEL; RADIATION DOSE; RADIATION SHIELD; SURVIVAL TIME; WHOLE BODY RADIATION;

ANTIGENS, CD34; CELL COUNT; DOSE FRACTIONATION; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELLS; HUMANS; LUNG; MODELS, STATISTICAL; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PROGNOSIS; SURVIVAL RATE; WHOLE-BODY IRRADIATION;

EID: 33847045523     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2006.10.029     Document Type: Article

References (23)

1. Shim B.Y., Lee M.A., Byun J.H., et al. High-dose chemotherapy and autologous stem cell transplantation for poor risk and recurrent non-Hodgkin's lymphoma: a single-center experience of 50 patients. Korean J Intern Med 19 (2004) 114-120
2. Reimer P., Schertlin T., Rudiger T., et al. Myeloablative radiochemotherapy followed by autologous peripheral blood stem cell transplantation as first-line therapy in peripheral T-cell lymphomas: first results of a prospective multicenter study. Hematol J 5 (2004) 304-311
3. Kang H.J., Shin H.Y., Choi H.S., et al. Autologous peripheral blood stem cell transplantation with BCVAC conditioning in childhood acute myeloid leukemia. Bone Marrow Transplant 33 (2004) 471-476
4. Russell-Jones R., Child F., Olavarria E., et al. Autologous peripheral blood stem cell transplantation in tumor-stage mycosis fungoides: predictors of disease-free survival. Ann N Y Acad Sci 941 (2001) 147-154
5. Varterasian M., Janakiraman N., Karanes C., et al. Transplantation in patients with multiple myeloma: a multicenter comparative analysis of peripheral blood stem cell and allogeneic transplant. Am J Clin Oncol 20 (1997) 462-466
6. McAfee S.L., Powell S.N., Colby C., et al. Dose-escalated total body irradiation and autologous stem cell transplantation for refractory hematologic malignancy. Int J Radiat Oncol Biol Phys 53 (2002) 151-156
7. Lohr F., Wenz F., Schraube P., et al. Lethal pulmonary toxicity after autologous bone marrow transplantation/peripheral blood stem cell transplantation for hematological malignancies. Radiother Oncol 48 (1998) 45-51
8. + cells in patients with advanced hematologic malignancies. Cancer 91 (2001) 2205-2213
9. + donor marrow T-cell depletion as the sole form of graft-versus-host disease prophylaxis in patients undergoing allogeneic bone marrow transplant from unrelated donors. J Clin Oncol 19 (2001) 1152-1159
10. + subsets on engraftment kinetics in allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant 35 (2005) 129-136
11. + cell dose in granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen-identical sibling transplantation. Blood 98 (2001) 3221-3227
12. + peripheral blood stem cells are associated with increased mortality from chronic graft-versus-host disease after allogeneic HLA-identical sibling transplantation. Leukemia 17 (2003) 869-875
13. + cell dose in allogeneic unmanipulated peripheral blood stem cell transplantation. Bone Marrow Transplant 31 (2003) 967-972
14. Stockerl-Goldstein K.E., Reddy S.A., Horning S.F., et al. Favorable treatment outcome in non-Hodgkin's lymphoma patients with "poor" mobilization of peripheral blood progenitor cells. Biol Blood Marrow Transplant 6 (2000) 506-512
15. Laughlin M.J., Barker J., Bambach B., et al. Hematopoietic engraftment and survival in adult recipients of umbilical cord blood from unrelated donors. N Engl J Med 344 (2001) 1815-1822
16. Savani B.N., Montero A., Wu C., et al. Prediction and prevention of transplant-related mortality from pulmonary causes after total body irradiation and allogeneic stem cell transplantation. Biol Blood Marrow Transplant 11 (2005) 223-230
17. Singh A.K., Karimpour S.E., Savani B.N., et al. Pretransplant pulmonary function tests predict risk of mortality following fractionated total body irradiation and allogeneic peripheral blood stem cell transplant. Int J Radiat Oncol Biol Phys 66 (2006) 520-527
18. Solomon S.R., Nakamura R., Read E.J., et al. Cyclosporine is required to prevent severe acute GVHD following T-cell-depleted peripheral blood stem cell transplantation. Bone Marrow Transplant 31 (2003) 783-788
19. Nakamura R., Battiwalla M., Solomon S., et al. Persisting posttransplantation cytomegalovirus antigenemia correlates with poor lymphocyte proliferation to cytomegalovirus antigen and predicts for increased late relapse and treatment failure. Biol Blood Marrow Transplant 10 (2004) 49-57
20. Srinivasan R., Chakrabarti S., Walsh T., et al. Improved survival in steroid-refractory acute graft versus host disease after nonmyeloablative allogeneic transplantation using a daclizumab-based strategy with comprehensive infection prophylaxis. Br J Haematol 124 (2004) 777-786
21. Therneau T.M., and Grambsch P.M. Modeling Survival Data: Extending the Cox Model (2000), Springer, New York 102-111
22. Atkinson K., Farrelly H., Cooley M., et al. Human marrow T-cell dose correlates with severity of subsequent acute graft-versus-host disease. Bone Marrow Transplant 2 (1987) 51-57
23. Reyes E., Garcia-Castro I., Esquivel F., et al. Granulocyte colony-stimulating factor (G-CSF) transiently suppresses mitogen-stimulated T-cell proliferative response. Br J Cancer 80 (1999) 229-235